作者
Huizhong Jiang,Shihao Zheng,Chuanqi Yang,Xiaobei Zhang,Haixiao Liu,Yanju Bao
摘要
Heterogeneity in tumor regulatory programs, cellular composition and spatial organization complicates target prioritization for natural compounds. We developed a spatial-context heterogeneous graph neural network ranker (SC-HGNN-Rank) that combines relation-aware graph representations with ranking optimization to integrate compound-target associations, transcriptional regulation, interaction networks, and single-cell and spatial information. The model ranked 600 candidate axes in colon adenocarcinoma (COAD), hepatocellular carcinoma (LIHC) and gastric adenocarcinoma (STAD). Under matched training conditions, mean Spearman correlations with the reference ranking were 0.965, 0.967 and 0.976 for leave-one-cancer-out, compound-group holdout and target-group holdout evaluations, respectively. The composite ranking objective improved mean Spearman correlation by 0.049 over a simple objective using the same encoder, whereas removing the spatial module reduced it by 0.147. Model ranking and multilayer evidence prioritized Quercetin-CDK1/MYB-Myeloid in COAD, 4',5-dihydroxyflavone (4',5-DHF)-AR/HDAC1-T/NK in LIHC, and Eriodyctiol-HSP90AB1/HOPX-Fibroblast in STAD. Expanded spatial analyses with expression-matched gene controls assessed associations between target expression and mapped cell abundance. Cellular thermal shift and drug affinity responsive target stability assays showed increased retention of target proteins after compound treatment. In HCT116, JHH-6 and MKN45 cells, the compounds reduced viability, colony formation, migration and invasion cell counts, and increased apoptosis. Target knockdown produced similar growth-inhibitory phenotypes, whereas overexpression attenuated compound-induced effects, supporting the involvement of CDK1, AR and HSP90AB1 in the respective responses. The accompanying Explorer supports candidate searches, evidence inspection and data export. By incorporating regulatory and spatial contexts into natural-compound prioritization, this study provides a reusable approach and experimentally supported candidates for target-directed pharmacological research in digestive system cancers.